Search

Your search keyword '"Cabada MM"' showing total 80 results

Search Constraints

Start Over You searched for: Author "Cabada MM" Remove constraint Author: "Cabada MM"
80 results on '"Cabada MM"'

Search Results

1. An Update on the Pathogenesis of Fascioliasis: What Do We Know?

2. Human Fascioliasis: Current Epidemiological Status and Strategies for Diagnosis, Treatment, and Control

4. Pretravel health advice among international travelers visiting Cuzco, Peru.

5. Sexual behavior in travelers visiting Cuzco.

6. Sacred journeys and pilgrimages: health risks associated with travels for religious purposes.

7. Malaria, Dengue Fever, and Leptospirosis in the Urabá Antioqueño Region, Colombia: Etiological and Molecular Characterization among Patients with Acute Undifferentiated Febrile Illness.

8. Respiratory Disease Surveillance in the Middle East and Latin America during the COVID-19 Pandemic, 2020-2022.

9. The Recombinase Polymerase Amplification Test for Strongyloides stercoralis Is More Sensitive than Microscopy and Real-Time PCR in High-Risk Communities of Cusco, Peru.

10. Subcapsular Liver Hematoma: One of the Many Faces of Acute Fascioliasis.

11. Fatal journeys: causes of death in international travellers in South America.

12. Molecular Characterization of Leptospira Species among Patients with Acute Undifferentiated Febrile Illness from the Municipality of Villeta, Colombia.

13. Establishment of a multisite umbrella cohort study protocol to describe the epidemiology and aetiologies of acute undifferentiated febrile illness in Latin America.

14. A PCR Test Using the Mini-PCR Platform and Simplified Product Detection Methods Is Highly Sensitive and Specific to Detect Fasciola hepatica DNA Mixed in Human Stool, Snail Tissue, and Water DNA Specimens.

15. Demographic Characteristics and Low Iron Status Markers Are Associated with Hemoglobin Levels and Anemia among Children Living at High Elevation in Cusco, Peru.

16. Eosinophilic Liver Abscess: A Case of Locally Acquired Fasciola hepatica in Alberta, Canada.

17. Causes of death among international travellers in Peru, 2017 to 2021.

18. Etiological characterization of acute undifferentiated febrile illness in Apartadó and Villeta municipalities, Colombia, during COVID-19 pandemic.

19. Nasopharyngeal Myiasis in Intensive Care Unit (ICU) Patients: Report of Two Cases.

20. Impact of international travel and diarrhea on gut microbiome and resistome dynamics.

21. Risk factors for acute mountain sickness in travellers to Cusco, Peru: coca leaves, obesity and sex.

22. Geospatial analysis of the associations between environmental contamination with livestock feces and children with chronic fascioliasis in the Anta province of Cusco, Peru.

23. The Differences in the Susceptibility Patterns to Triclabendazole Sulfoxide in Field Isolates of Fasciola hepatica Are Associated with Geographic, Seasonal, and Morphometric Variations.

24. Prediction of the need for intensive oxygen supplementation during hospitalisation among subjects with COVID-19 admitted to an academic health system in Texas: a retrospective cohort study and multivariable regression model.

25. Comparison of Liver Condemnation and Bile Microscopy As Tools to Estimate Fasciola hepatica Prevalence and Burden in the Anta Province of Cusco in Peru.

26. Plasma cytokines during acute human fascioliasis.

27. A Comparison of the Risk for Chronic Fascioliasis between Children 3 to 5 Years and Children 6 to 12 Years of Age in the Cusco Region of Peru.

28. Triclabendazole Treatment Failure for Fasciola hepatica Infection among Preschool and School-Age Children, Cusco, Peru 1 .

29. Stunting in pre-school and school-age children in the Peruvian highlands and its association with Fasciola infection and demographic factors.

30. Fasciola hepatica Infection Risk for Adult Household Members Living with Children with Fascioliasis in Cusco, Peru.

33. Adaptive Radiation of the Flukes of the Family Fasciolidae Inferred from Genome-Wide Comparisons of Key Species.

34. Stunting Is Preceded by Intestinal Mucosal Damage and Microbiome Changes and Is Associated with Systemic Inflammation in a Cohort of Peruvian Infants.

35. Strongyloides stercoralis Infection at Different Altitudes of the Cusco Region in Peru.

36. Socioeconomic Factors Associated with Fasciola hepatica Infection Among Children from 26 Communities of the Cusco Region of Peru.

37. Recent developments in the epidemiology, diagnosis, and treatment of Fasciola infection.

38. Intestinal Myiasis Caused by Sarcophaga spp. in Cusco, Peru: A Case Report and Review of the Literature.

39. Intestinal cestodes.

40. Prevalence and Risk Factors for Human Cystic Echinococcosis in the Cusco Region of the Peruvian Highlands Diagnosed Using Focused Abdominal Ultrasound.

41. Case-Case Analysis Using 7 Years of Travelers' Diarrhea Surveillance Data: Preventive and Travel Medicine Applications in Cusco, Peru.

42. Recombinase Polymerase Amplification Compared to Real-Time Polymerase Chain Reaction Test for the Detection of Fasciola hepatica in Human Stool.

43. Hymenolepis nana Impact Among Children in the Highlands of Cusco, Peru: An Emerging Neglected Parasite Infection.

44. Fasciola hepatica Infection in an Indigenous Community of the Peruvian Jungle.

45. Kato-Katz and Lumbreras rapid sedimentation test to evaluate helminth prevalence in the setting of a school-based deworming program.

46. Treatment Failure after Multiple Courses of Triclabendazole among Patients with Fascioliasis in Cusco, Peru: A Case Series.

47. Human Nasal Myiasis Caused by Oestrus ovis in the Highlands of Cusco, Peru: Report of a Case and Review of the Literature.

48. [Massive hookworm infection as a cause of intestinal bleeding and severe anemia].

49. Recombinase polymerase amplification-based assay to diagnose Giardia in stool samples.

50. Prevalence of intestinal helminths, anemia, and malnutrition in Paucartambo, Peru.

Catalog

Books, media, physical & digital resources